Envestnet Asset Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,201
| Closed | -$38K | – | 4090 |
|
|
2022
Q3 | $38K | Buy |
9,201
+3,182
| +53% | +$13.1K | ﹤0.01% | 3828 |
|
|
2022
Q2 | $31K | Buy |
6,019
+16
| +0.3% | +$82 | ﹤0.01% | 3858 |
|
|
2022
Q1 | $62K | Sell |
6,003
-835
| -12% | -$8.62K | ﹤0.01% | 3845 |
|
|
2021
Q4 | $77K | Buy |
6,838
+4,129
| +152% | +$46.5K | ﹤0.01% | 3784 |
|
|
2021
Q3 | $55K | Buy |
2,709
+976
| +56% | +$19.8K | ﹤0.01% | 3633 |
|
|
2021
Q2 | $43K | Buy |
1,733
+539
| +45% | +$13.4K | ﹤0.01% | 3608 |
|
|
2021
Q1 | $34K | Buy |
1,194
+612
| +105% | +$17.4K | ﹤0.01% | 3465 |
|
|
2020
Q4 | $12K | Buy |
+582
| New | +$12K | ﹤0.01% | 3260 |
|